Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1549875-93-5

Post Buying Request

1549875-93-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1549875-93-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1549875-93-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,4,9,8,7 and 5 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1549875-93:
(9*1)+(8*5)+(7*4)+(6*9)+(5*8)+(4*7)+(3*5)+(2*9)+(1*3)=235
235 % 10 = 5
So 1549875-93-5 is a valid CAS Registry Number.

1549875-93-5Relevant articles and documents

Synthesis and structure-activity relationships of amino acid conjugates of cholanic acid as antagonists of the EphA2 receptor

Russo, Simonetta,Incerti, Matteo,Tognolini, Massimiliano,Castelli, Riccardo,Pala, Daniele,Hassan-Mohamed, Iftiin,Giorgio, Carmine,De Franco, Francesca,Gioiello, Antimo,Vicini, Paola,Barocelli, Elisabetta,Rivara, Silvia,Mor, Marco,Lodola, Alessio

, p. 13043 - 13060 (2013/11/06)

The Eph-ephrin system plays a critical role in tumor growth and vascular functions during carcinogenesis. We had previously identified cholanic acid as a competitive and reversible EphA2 antagonist able to disrupt EphA2-ephrinA1 interaction and to inhibit EphA2 activation in prostate cancer cells. Herein, we report the synthesis and biological evaluation of a set of cholanic acid derivatives obtained by conjugation of its carboxyl group with a panel of naturally occurring amino acids with the aim to improve EphA2 receptor inhibition. Structure-activity relationships indicate that conjugation of cholanic acid with linear amino acids of small size leads to effective EphA2 antagonists whereas the introduction of aromatic amino acids reduces the potency in displacement studies. The β-alanine derivative 4 was able to disrupt EphA2-ephrinA1 interaction in the micromolar range and to dose-dependently inhibit EphA2 activation on PC3 cells. These findings may help the design of novel EphA2 antagonists active on cancer cell lines.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1549875-93-5